跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DALACIN C clindamycin 600 mg/4 mL (as phosphate) injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
DALACIN C clindamycin 600 mg/4 mL (as phosphate) injection ampoule
Approved
STANDARD
DALACIN C clindamycin 600 mg/4 mL (as phosphate) injection ampoule
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
3501fb416618f693
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
3501fb416618f693
Product Name
DALACIN C clindamycin 600 mg/4 mL (as phosphate) injection ampoule
Artg Id
47636
Artg Name
DALACIN C clindamycin 600mg/4mL (as phosphate) injection ampoule
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1994-04-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ea4be98e1e7c942f52a2dd8f6bd15a61.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/5cd0e49057181d36e518975bdd26c978.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
3501fb416618f693
Type
Standard
Back to TGA Approvals